Skip to main content
Premium Trial:

Request an Annual Quote

Elan Licenses GeneGo's Data Suite

NEW YORK (GenomeWeb News) — Elan Pharmaceuticals has licensed GeneGo’s MetaCore suite, GeneGo said Tuesday. Elan plans to use the software and data suite in its neurology and autoimmune programs.
“MetaCore has substantial knowledge content coverage in the areas of CNS and autoimmune diseases, which the Elan scientists can leverage in their innovative research,” said Julie Bryant, GeneGo's vice president of business development, in a statement.
Financial terms of the deal were not released.